|
WO2004016785A1
|
|
Method of examining atopic dermatitis
|
|
AU2003252417A1
|
|
Protease inhibitor
|
|
WO2004031386A1
|
|
Method of examining atopic dermatitis
|
|
WO2004005509A1
|
|
Method of examining allergic disaese and drug for treating the same
|
|
WO2004016783A1
|
|
Method of examining atopic dermatitis
|
|
EP1498493A1
|
|
Method of examining allergic disease
|
|
EP1486562A1
|
|
Method of examining allergic disease
|
|
AU2002354228A1
|
|
Method of examining allergic disease
|
|
EP1422297A1
|
|
Method of testing for bronchial asthma
|
|
WO03010310A1
|
|
Method of examining allergic disease
|
|
WO02088349A1
|
|
Method of examining allergic disease using cathepsin-c alternative splicing form as indication
|
|
EP1347051A1
|
|
Method of examining allergic disease
|
|
EP1284289A1
|
|
Method of examining allergic disease
|
|
WO0233069A1
|
|
Method of examining allergic disease
|
|
WO0226962A1
|
|
Method of examining allergic disease
|
|
WO0224903A1
|
|
Method of examining allergic disease
|
|
WO0165259A1
|
|
Method of examining allergic diseases
|
|
WO0073435A1
|
|
Pollinosis-associated gene 441
|
|
WO0073440A1
|
|
Pollinosis-associated gene 787
|
|
WO0073439A1
|
|
Pollinosis-associated gene 465
|
